Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery


Study Number
49517
Phase
2
Purpose

Phase 2, open-label study of AVB-620 in women with primary, nonrecurrent and nonmetastatic breast cancer undergoing surgery.

Full Title

An Open-Label, Single-Arm, Phase 2 Study of AVB-620 in Women with Primary Nonrecurrent Breast Cancer Undergoing Surgery

ClinicalTrials.Gov ID
NCT03113825

To inquire about participating in these studies, call 1-800-ROSWELL (1-800-767-9355) or e-mail askroswell@roswellpark.org.